A Phase II, Randomised, Double Blind, Placebo Controlled, Six Way Crossover Study to Assess the Bronchodilator Effect of RPL554 Administered on Top of Salbutamol and Ipratropium in Patients With COPD.
Phase of Trial: Phase II
Latest Information Update: 21 Sep 2016
At a glance
- Drugs RPL 554 (Primary) ; Ipratropium bromide; Salbutamol
- Indications Chronic obstructive pulmonary disease
- Focus Pharmacodynamics
- Sponsors Verona Pharma
- 08 Sep 2016 Status changed from active, no longer recruiting to completed.
- 24 Nov 2015 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 27 Oct 2015 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History